Key Insights

Highlights

Success Rate

91% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.8%

1 terminated out of 26 trials

Success Rate

90.9%

+4.4% vs benchmark

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

10%

1 of 10 completed with results

Key Signals

1 with results91% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (8)
P 1 (1)
P 2 (2)
P 4 (1)

Trial Status

Completed10
Unknown7
Not Yet Recruiting4
Recruiting4
Terminated1

Trial Success Rate

90.9%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (26)

Showing 20 of 20 trials
NCT06638502Phase 1RecruitingPrimary

Safety of HRX215 in Patients After Minor and Major Liver Resection

NCT07511907Not ApplicableNot Yet Recruiting

Routine Intraoperative White Test for Bile Leak Detection in Liver Resection

NCT07445412Recruiting

Italian Group of Regenerative and Occlusive Worldwide-used Techniques of Hepatic Hypertrophy

NCT07385521Recruiting

The Use of Artificial Intelligence for the Prediction of Recurrence After Resection of Colorectal Liver Metastases

NCT07180641Completed

National Registry of Hepatic Metastases From Non-Colorectal Cancer"

NCT07142876Not ApplicableNot Yet RecruitingPrimary

Evaluation Of Liver Resection Using Harmonic Scalpel Versus Cavitron Ultrasonic Surgical Aspirator (CUSA).

NCT06980792Completed

Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases

NCT06905015Not ApplicableRecruiting

Stroke Volume Variation Versus Central Venous Pressure Guidance for Reducing Perioperative Blood Loss During Open Liver Resection

NCT06905041Not Yet RecruitingPrimary

Preoperative Anemia Affected to Postoperative Outcomes in Liver Resection

NCT06894524Not Yet Recruiting

Retrospective Clinical Validation of HepatoPredict

NCT04692259Not ApplicableUnknown

May the Risk of PHLF be Predicted With Preoperative Liver Gadoxetate MRI

NCT03917017Not ApplicableUnknownPrimary

The Evaluation of Surgical Decisions and Prognosis of the Radiomics and Watson Artificial Intelligence in Patients With Hepatocellular Carcinoma

NCT04889235Unknown

Diaphragm Kinetics Following Hepatic Resection

NCT02216773Not ApplicableCompletedPrimary

Regeneration of Liver: Portal Vein Embolization Versus Radiofrequency Assisted Ligation for Liver Hypertrophy (REBIRTH)

NCT03600168UnknownPrimary

Post-Market Clinical Study to Confirm Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding in Liver Surgery

NCT03904667UnknownPrimary

Application of Watson for Oncology in Hepatocellular Carcinoma Surgery

NCT03811704Phase 2UnknownPrimary

Real-time Navigation for Laparoscope Liver Resections Using Fusion 3D Imaging and Indocyanine Green Fluorescence Imaging

NCT01921985Phase 2TerminatedPrimary

Terlipressin Administration in Patients Undergoing Major Liver Resection

NCT02834338Not ApplicableCompleted

Enhanced Perioperative Mobilization (EPM) Trial

NCT01858987Not ApplicableCompletedPrimary

Stapler vs. LigaSure in Elective Hepatic Resection

Scroll to load more

Research Network

Activity Timeline